REPLAY
Replay is a genome writing company, which aims to define the future of genomic medicine through reprogramming biology by writing and delivering big DNA.
REPLAY
Industry:
Biotechnology Therapeutics
Founded:
2021-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.replay.bio
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
55 M USD
Current Advisors List
Investors List
OMX Ventures
OMX Ventures investment in Seed Round - Replay
Kohlberg Kravis Roberts
Kohlberg Kravis Roberts investment in Seed Round - Replay
Artis Ventures (AV)
Artis Ventures (AV) investment in Seed Round - Replay
Salt Ventures
Salt Ventures investment in Seed Round - Replay
DeciBio Ventures
DeciBio Ventures investment in Seed Round - Replay
Lansdowne Partners
Lansdowne Partners investment in Seed Round - Replay
Axial VC
Axial VC investment in Seed Round - Replay
Artis Ventures (AV)
Artis Ventures (AV) investment in Seed Round - Replay
Official Site Inspections
http://www.replay.bio Semrush global rank: 4.44 M Semrush visits lastest month: 2.48 K
- Host name: 172.67.189.84
- IP address: 172.67.189.84
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Replay"
Replay
Replay launches big DNA HSV gene therapy company, Telaria, focused on rare skin diseasesSee details»
Team - Replay
Replay has assembled a team of industry leaders, entrepreneurs, scientists, and physicians dedicated to authoring the future of genomic medicine.See details»
Management | Team - Replay
Replay has assembled a team of industry leaders, entrepreneurs, scientists, and physicians dedicated to authoring the future of genomic medicine.See details»
Replay - Crunchbase Company Profile & Funding
Jul 25, 2022 · Replay is a genome writing company, which aims to define the future of genomic medicine through reprogramming biology by writing and delivering big DNA. Where is Replay's …See details»
Replay Overview | SignalHire Company Profile
Replay is a genome writing company, which aims to define the future of genomic medicine through reprogramming biology by writing and delivering big DNA.See details»
Replay - LinkedIn
Replay is a genome writing company, which aims to define the future of genomic medicine through reprogramming biology by writing and delivering big DNA.See details»
Replay - Crunchbase Company Profile & Funding
Who invested in Replay? Replay is funded by Artis Ventures (AV). When was the last funding round for Replay? Replay closed its last funding round on Jul 7, 2020 from a Seed round. Who …See details»
Replay Company Profile - Office Locations, Competitors, Revenue …
Replay is a company developing an enzyme writing product platform for reprogramming biology by writing and delivering big DNA constructs. It offers genomic products, synthetic gene …See details»
Replay Launches With $55M Seed Round - San Diego Business …
Aug 12, 2022 · Replay, a biotech firm with dual headquarters in San Diego and London, has emerged from stealth with $55 million in seed financing to advance its platform for writing …See details»
Replay - Company Profile - Tracxn
Oct 23, 2024 · Replay - Provider of genomic reprogramming platform for writing and delivering big DNA. Raised a total funding of $55M over 2 rounds from 8 investors. Founded by David Knipe …See details»
Replay Launches with $55 Million Seed to Reprogram Biology by …
Jul 25, 2022 · San Diego, California and London, UK, 25 July 2022 – Replay, a genome writing company reprogramming biology by writing and delivering big DNA, today announced its …See details»
Founders | Team - Replay
Replay has assembled a team of industry leaders, entrepreneurs, scientists, and physicians dedicated to authoring the future of genomic medicine.See details»
Replay launches to reprogram biology by writing and delivering …
Jul 25, 2022 · Replay, a genome writing company reprogramming biology by writing and delivering big DNA, has launched with $55 million in seed financing. The round was led by …See details»
Replay Launches with $55 Million Seed to Reprogram Biology by …
Replay’s genomic medicine toolkit encompasses a portfolio of disruptive platform technologies to write and deliver big DNA, including a high payload capacity HSV delivery platform, a …See details»
Replay establishes distinguished Scientific Advisory Board
Oct 17, 2022 · Replay is a genome writing company, which aims to define the future of genomic medicine through reprogramming biology by writing and delivering big DNA.See details»
Replay establishes distinguished Scientific Advisory Board of …
Oct 17, 2022 · The newly formed SAB will provide input into Replay’s strategy, portfolio of next-generation genomic and cell therapy medicines, and associated technology platforms. The …See details»
Replay Launches with $55 Million Seed to Reprogram Biology
Jul 25, 2022 · San Diego, California and London, UK, 25 July 2022 – Replay, a genome writing company reprogramming biology by writing and delivering big DNA, today announced its …See details»
Biotechnology Innovation Organization | BIO
The Biotechnology Innovation Organization is the world's largest biotech trade association. Learn about BIO, register for events and explore member services.See details»
News - Replay
Oct 31, 2022 · Replay launches its first HSV gene therapy company, Eudora, focused on retinal eye diseaseSee details»